Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Morice, P.
Right arrow Articles by Castaigne, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morice, P.
Right arrow Articles by Castaigne, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:592-598, 2003
© 2003 European Society for Medical Oncology

Original Paper

Prognostic factors for patients with advanced stage serous borderline tumours of the ovary

P. Morice1,+, S. Camatte1, A. Rey2, D. Atallah1, C. Lhommé3, P. Pautier3, C. Pomel1, J.-F. Coté4, C. Haie-Meder5, P. Duvillard4 and D. Castaigne1

Departments of 1 Surgery, 2 Biostatistics, 3 Medical Oncology, 4 Pathology and 5 Radiotherapy, Institut Gustave Roussy, Villejuif, France

Received 28 August 2002; revised 15 November 2002; accepted 3 December 2002

Background:

The aim of this study was to determine the prognostic factors for patients with advanced stage, low malignant potential ovarian tumour (LMPOT).

Patients and methods:

A retrospective review of 80 patients with serous LMPOT and peritoneal implants treated at or referred to our institution was carried out.

Results:

Sixty-five patients had non-invasive implants. Fifteen patients had invasive implants. Twenty-nine patients had stage II and 51 patients had stage III disease. Three patients died of evolutive invasive disease and four of complications of treatment. The only prognostic factor of progression to ‘evolutive invasive disease’ is the pathologic subtype of peritoneal implants. The 5-year rates of evolutive invasive disease in patients with non-invasive implants and invasive implants were 2% and 31%, respectively (P <0.002).

Conclusions:

In this series, the only prognostic factor for patients with advanced stage borderline tumour is the type of peritoneal implant. More patients died of the treatment’s complications than of the disease itself. The patients’ prognosis with non-invasive implants seems to be excellent, and conservative management could be discussed in younger patients.

Key words: borderline tumour, invasive implants, non-invasive implants, ovary, peritoneal implants


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The OncologistHome page
A. Kane, C. Uzan, A. Rey, S. Gouy, S. Camatte, P. Pautier, C. Lhomme, C. Haie-Meder, P. Duvillard, and P. Morice
Prognostic Factors in Patients with Ovarian Serous Low Malignant Potential (Borderline) Tumors with Peritoneal Implants
Oncologist, June 1, 2009; 14(6): 591 - 600.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. Cadron, K. Leunen, T. Van Gorp, F. Amant, P. Neven, and I. Vergote
Management of Borderline Ovarian Neoplasms
J. Clin. Oncol., July 10, 2007; 25(20): 2928 - 2937.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Camatte, P. Morice, D. Atallah, A. Thoury, P. Pautier, C. Lhomme, P. Duvillard, and D. Castaigne
Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients
Ann. Onc., April 1, 2004; 15(4): 605 - 609.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Morice, A. Thoury, J.C. Sabourin, S. Camatte, D. Atallah, J.P. Armand, P. Madelenat, P. Duvillard, and D. Castaigne
Unusual Abdominal and Pelvic Tumors: CASE 2. SPONTANEOUS REGRESSION OF PERITONEAL IMPLANTS IN BORDERLINE OVARIAN TUMOR AFTER SALPINGO-OOPHORECTOMY
J. Clin. Oncol., September 15, 2003; 21(18): 3536 - 3538.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.